Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
10.70
+0.20 (1.90%)
At close: May 12, 2025
-50.23%
Market Cap 1.22B
Revenue (ttm) 7.02M
Net Income (ttm) -36.36M
Shares Out 119.80M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 872,424
Average Volume 695,650
Open 10.60
Previous Close 10.50
Day's Range 10.20 - 10.90
52-Week Range 7.50 - 23.20
Beta 0.38
RSI 43.65
Earnings Date Apr 30, 2025

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablet, capsule, liquid, and ointment. The company offers its products in various therapeutic areas, including antibacterial, antiulcerant, NSAIDs, analgesics and antipyretic, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAIDs, antibacterial preparations, antidopaminergic, antihistamines, and other products. Central Pharmaceuticals Ltd. was incorporated in 1980 ... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 74
Stock Exchange Dhaka Stock Exchange
Ticker Symbol CENTRALPHL
Full Company Profile

Financial Performance

In 2024, Central Pharmaceuticals's revenue was 29.60 million, an increase of 0.93% compared to the previous year's 29.33 million. Losses were -42.42 million, -3.49% less than in 2023.

Financial Statements

News

There is no news available yet.